Macquarie Group LTD Si Bone, Inc. Transaction History

Macquarie Group LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$15.75 - $21.38 $393,592 - $534,286	-24,990 Reduced 16.52%	126,301 $2.65 Million
Q3 2023 Nov 14, 2023	BUY	$20.22 - $27.36 $278,672 - $377,075	13,782 Added 10.02%	151,291 $3.21 Million
Q2 2023 Aug 14, 2023	BUY	$19.39 - $28.9 $2.67 Million - $3.97 Million	137,509 New	137,509 $3.71 Million
Q3 2022 Nov 14, 2022	SELL	$12.2 - $18.71 $22,387 - $34,332	-1,835 Closed	0 $32,000
Q2 2022 Aug 15, 2022	BUY	$12.05 - $22.74 $22,111 - $41,727	1,835 New	1,835 $24,000
Q4 2021 Feb 11, 2022	SELL	$18.75 - $24.8 $12.8 Million - $16.9 Million	-682,816 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$19.65 - $31.89 $49,812 - $80,841	-2,535 Reduced 0.37%	682,816 $14.6 Million
Q2 2021 Aug 13, 2021	BUY	$29.4 - $35.96 $13.4 Million - $16.4 Million	456,061 Added 198.9%	685,351 $21.6 Million
Q1 2021 May 14, 2021	BUY	$28.09 - $34.02 $4.19 Million - $5.08 Million	149,303 Added 186.66%	229,290 $7.29 Million
Q4 2020 Feb 16, 2021	BUY	$20.44 - $30.88 $1.63 Million - $2.47 Million	79,987 New	79,987 $2.39 Million
Q1 2019 May 15, 2019	SELL	$17.29 - $22.35 $496,810 - $642,204	-28,734 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$16.79 - $21.0 $482,443 - $603,414	28,734 New	28,734 $600,000

139

41.4M

266K

252K

Ticker SIBN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 34,305,000
Market Cap $417M
Description
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.